AIHC Capital Management Ltd 13F Portfolio

CIK 2103725 Filing since Q4 2025 Q2 2026 filed Aug 13, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 13, 2026.

Portfolio Snapshot

4 positions · Q2 2026

AIHC Capital Management Ltd reported 4 positions worth $104.24M for the quarter ended Jun 30, 2026, down 12.9% on the prior quarter. It opened 0 new positions, added to 2, trimmed 1 and exited 1. Its largest holding is Revolution Medicines, Inc. at 54.5% of the portfolio.

Portfolio Value
$104.24M
-12.9% QoQ · — YoY
Positions
4
0 new · 1 sold out
Top 10 Concentration
100%
of portfolio value
Largest Position
RVMD 54.5%
Revolution Medicines, Inc.
Net Buying
-$84.43M
$16.02M bought · $100.46M sold
Turnover
14.3%
of the portfolio traded
Top Sector
Healthcare
100% of value
Track Record
3
quarters on file since Q4 2025

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

1 sectors
100%
Healthcare
Healthcare100%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

Healthcare

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
ORIC Oric Pharmaceuticals, Inc. +1.37M +55.7% $14.83M 39.77%
NBP NovaBridge Biosciences +615.1K +27.2% $1.20M 5.38%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
RVMD Revolution Medicines, Inc. -525.8K -63.4% $98.48M 54.46%
COGT Cogent Biosciences, Inc. -51.4K -100.0% $1.98M Exited

New Positions

Q2 2026

No new positions this quarter.

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
COGT Cogent Biosciences, Inc. -51.4K $1.98M 1.65%
Holdings · Q2 2026

4 Positions

As ofJun 30, 2026
Value$104.24M
Top 10100%
Avg position$26.06M
# Activity
Showing all 4 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at AIHC Capital Management.

About AIHC Capital Management Ltd’s 13F Portfolio

What are AIHC Capital Management Ltd’s largest holdings?

As of its Q2 2026 13F filing, AIHC Capital Management Ltd’s five largest positions were Revolution Medicines, Inc. (RVMD) at 54.5%, Oric Pharmaceuticals, Inc. (ORIC) at 39.8%, NovaBridge Biosciences (NBP) at 5.4%, Korro Bio, Inc. (KRRO) at 0.4% of the reported portfolio.

How much is AIHC Capital Management Ltd’s portfolio worth?

AIHC Capital Management Ltd reported a 13F portfolio worth $104.24M across 4 positions for Q2 2026. That is down 12.9% from the previous quarter.

What did AIHC Capital Management Ltd buy in Q2 2026?

Its largest purchases by value were Oric Pharmaceuticals, Inc. ($14.83M), NovaBridge Biosciences ($1.20M). It opened 0 new positions.

What did AIHC Capital Management Ltd sell in Q2 2026?

Its largest sales by value were Revolution Medicines, Inc. ($98.48M), Cogent Biosciences, Inc. ($1.98M). It exited 1 positions entirely.

Where does this data come from?

From the Form 13F-HR reports AIHC Capital Management Ltd files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.